REKA: Rekah Pharmaceutical Industry Ltd. - Summary | Jitta

Rekah Pharmaceutical Industry Ltd.

ISR:REKA

Price
₪11.08
Loss Chance
50.0%
2.38JITTA SCORE
0.51%Over Jitta Line
Jitta Ranking
71 / 421
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (38)
Recent Business Performance (39)
Financial Strength (52)
Return to Shareholders (0)
Competitive Advantage (21)
Jitta Signs
Revenue and EarningEarning loss detected in 2025
Operating MarginInconsistent
Recent Business PerformanceEarning decline 82.27% in the last year
CapExVery High
SG&A to SalesIncreasing Every Year
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
2.38
0.51%
2.84
95.01%
Pharmaceuticals
0.43
100.00%
2.37
100.00%
n/a
100.00%
COMPANY DESCRIPTION
Rekah Pharmaceutical Industry Ltd. engages in the manufacture, marketing, sale, and distribution of pharmaceuticals, cosmetics, vitamins and nutritional supplements, and medical devices in Israel. The company offers steroids, antibiotics, and ophthalmic products, as well as dermo-cosmetics products. Its portfolio of products comprise Rx and OTC drugs, and medical devices used in various therapeutic fields, such as urinary tract pain, steroid anti-inflammatories, cough, expectoration and bronchitis, motion sickness, runny nose and congestion, skin disinfection, wounds, burns and insect bites, eye infections, glaucoma, dryness, allergies, fever and pain relief, mouth, depression and anxiety, muscle and joint pain, antibiotics, fungal infections, anemia and nutritional deficits, ear pain, babies and children, etc. The company was founded in 1947 and is based in Holon, Israel.